Utah Medical Products Reports Q2 2026 Financial Results

What Happened
Utah Medical Products, Inc. (UTMD) filed a Form 8-K on July 23, 2026 to furnish financial information for the three- and six-month periods ended June 30, 2026. The filing incorporates a press release (Exhibit 99.1) dated July 23, 2026 that presents the company’s quarterly results and includes forward-looking statements relating to 2026 and beyond.

Key Details

• Filed Form 8-K on July 23, 2026 under Item 2.02 (Results of Operations and Financial Condition).
• Press release is attached as Exhibit 99.1 and covers the three and six months ended June 30, 2026.
• The press release includes forward-looking statements about 2026 and future expectations.
• Item 9.01 lists the financial information exhibit (Exhibit 99.1) filed with the report.

Why It Matters
This 8-K provides UTMD’s latest quarterly performance data and management’s outlook, which are important for assessing near-term revenue, earnings trends and guidance. Retail investors should review Exhibit 99.1 (the July 23, 2026 press release) for the specific figures (revenue, net income, margins, or guidance) and monitor subsequent filings (e.g., Form 10-Q) for audited financial details and additional context.